Maryland State Retirement & Pension System’s Adaptive Biotechnologies ADPT Stock Holding History

Maryland State Retirement & Pension System’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,810	Closed	-$219K	–	1497
2021 Q4	$219K	Hold	7,810	–	–	0.01%	1466
2021 Q3	$261K	Hold	7,810	–	–	0.01%	1426
2021 Q2	$307K	Buy	7,810 +1,785	+30%	+$69.4K	0.01%	874
2021 Q1	$243K	Buy	+6,025	New	+$326K	0.01%	930

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Maryland State Retirement & Pension System's ADPT Position: Q1 2022 in Review

Maryland State Retirement & Pension System sold out of Adaptive Biotechnologies (ADPT) in Q1 2022, closing a stake of 7,810 shares — an estimated $219K sold.

Maryland State Retirement & Pension System first reported a position in ADPT in Q1 2021 and held it in 4 quarters. The position peaked at $307K in Q2 2021. 221 funds tracked by Wall St. Rank hold ADPT as of Q1 2022.

Maryland State Retirement & Pension System reported no remaining Adaptive Biotechnologies position as of Q1 2022 after selling out during the quarter.
Maryland State Retirement & Pension System sold 7,810 Adaptive Biotechnologies shares in Q1 2022, an estimated $219K.
Maryland State Retirement & Pension System first reported a position in Adaptive Biotechnologies in Q1 2021 and held it in 4 quarters.
Maryland State Retirement & Pension System's Adaptive Biotechnologies position peaked at $307K in Q2 2021.
221 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2022.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2022, filed 11 Apr 2022.